China Monitoring Program Targets Drug Safety

The Chinese government says that the State Council (Beijing), the country’s cabinet, has approved a plan to establish a credit rating system and to intensify monitoring of pharmaceutical companies over the next five years, in an effort to crack down on drug safety. The State Council approved the plan in an executive meeting on December 7, presided over by premier Wen Jiabao. The plan aims to significantly increase the level of drug safety by ensuring all pharmaceutical products meet the standards of a newly revised regulation on the quality management of...

If you have already signed up for access to Chemical Week Regulatory Watch, please log in here.

Forgot your user ID or password?
Click here to have it sent to you.